| Net loss | |
| Depreciation and amortization | 429.35K |
| Compensation associated with issuance of stock options | 241.86K |
| Decrease in accounts receivable | -28.68K |
| (Increase) in prepaid expenses | |
| (Increase) decrease in other assets | 1.11K |
| Decrease in accounts payable and accrued expenses | -10.84K |
| Decrease in deferred revenue | 1.36M |
| Net cash provided by (used in) operating activities | |
| Acquisition of property and equipment | -83K |
| Acquisition of intangibles | |
| Net cash used in investing activities | |
| Payments on capital lease obligation | |
| Proceeds from exercise of warrants | |
| Proceeds from employee stock option exercises | |
| Net proceeds from issuance of common stock | |
| Net cash provided by financing activities | |
| Net increase in cash and cash equivalents | |
| Cash and cash equivalents at beginning of period | 1.78M |
| Cash and cash equivalents at end of period | 333.67K |
| Cashless exercise of warrants | |
| Interest | 28.17K |